5Akazawa H,Komuro I. Cardiac transcription factor Nkx2.5: Its role in cardiac development and diseases [ J ]. Pharmacol Ther, 2005, 107(2) :252 -268.
6Koizumi K, Lintas C, Nirenberg M,et al. Mutations that affect the ability of the vnd/NK-2 homeoprotein to regulate gene expression: Transgenic alterations and tertiary structure [ J ]. Proc Natl Acad Sci U S A ,2003,100(6) :3119 - 3124.
7MeElhinney DB, C, eiger E, Blinder J,et al. Nkx2.5 mutations in patients with congenital heart diease[J]. J Am Coil Cardiol,2003,42 (9) : 1650 - 1655.
8Reamon-Buettner SM, Borlak J. GATA4 zinc finger mutations as a molecular rationale for septation defects of the human heart [ J ]. J Med Genet,2005,42(5 ) :e32.
9EUiott DA, Kirk EP, Yeoh T, et al. Cardiac homeobox gene NKX2.5 mutations and congenital heart disease: associations with atrial septal defect and hypoplasfic left heart syndrome [ J ]. J Am Coll Cardiol,2003,41 ( 11 ) :2072 -2076.
10Zang MX,Li Y, Xue LX,et al. Cooperative activation of atrial natriuretic peptide promoter by dHAND and MEF2C [ J ]. J Cell Biochem,2004,93(6) : 1255 - 1266.
二级参考文献30
1Bonnardeaux A,Davies E,Jeunemaitre X,et al. Angiotensin I type I receptor gene polymorphisms in human essential hypertension[J]. Hypertension, 1994,24 : 63-- 69.
2Katsuya T,Koite G,Yee TW,et al. Association of angiotensiogen T235 variant with increased risk of coronary heart disease [J]. Lancet, 1995,345 :1600-- 1603.
3Furuta H,Deng-Fu Guo,Inagami T. Molecular cloning and sequending of he gene encoding human angiotensin I type 1 receptor[J]. Biochem Biophys Res Commun,1992,28:17--26.
4Van Creel PP,Pinto YM,Voors A.A,et al. Angiotensin I type I receptor A1166C polymorphism is associated with an increased response to angiotensin I in human arteries[J]. Hypertension, 2000,35 : 717-- 721.
5Carluccio M, Soccio M, De Caterina R, et al. Aspects of gene polymorphisms in cardiovascular diseases:the renin-angiogensin system[J]. Eur J Clin Invest,2001,31:1--14.
6Tiert L,Bonnardeaux A,Poirier O,et al. Synergisitic effects of angiotensin converting enzyme and angiotensin I tyep 1 receptor gene plymorphisms on risk of myocardial infarction [J].Lancet, 1994,344 : 910-- 913.
7Petes S,Gotting B,Trummel M,et al. Valsartan for prevention of restenosis after stenting of type B2/C lesions: the VAL-PREST trial[J]. J Invasive Cardial , 2001,13 ( 2 ) :93--97.
8Nestel P,Sinmons L,Barter P,et al. A comparative study of the efficacy of simvastatin and gemfibrozil in combined hyperlipoproteinemia:prediction of response by baseline lipids, apoE genotype, lipoprotein (a) and insulin [J ]. Atherosclerosis, 1997,129:23
9Nassar BA, Dunn J,Title LM,et al. Relation of genetic polymorphisms of apolipoprotein E,angiotensin coverting enzyme,apolipoprotein B-100,and glycoprotein Ⅰ a and earlyonset coronary artery heart disease [J]. Clin Biochem, 1999, 32:275-2825.
10Hixon JE, Vernier DT. Restriction isotyping of human apolipoprotein E by gene amplification and clevage with HhalI [J]. J Lipid Res, 1990, 31: 545-548.
3Jenkins KJ, Correa A, Feinstein JA, et al. Noninherited risk factors and congenital cardiovascular defects : current knowledge : a scientific statement from the American Heart Association Council on Cardiovascular Disease in the Young: endorsed by the American Academy of Pediatrics[ J]. Circulation, 2007, 115 (23) :2995 - 3014.
4Zeppenfeld K, Schalij M J, Bartelings MM, et al. Catheter ablation of ventricular tachycardia after repair of congenital heart disease: electroanatomic identification of the critical right ventricular isthmus [J]. Circulation, 2007, 116(20) :2241 -2252.
5Eivera-Rodriguez L, Cline B. Incidence and clinical features of arrhythmias after surgical treatment of congenital heart disease [ J ]. Arch Cardiol Mex, 2007, 77. (Suppl 2) :S2 -51-S2 -53.
6Pierpont ME, Basson CT, Bensorl DW Jr, et al. Genetic basis for congenital heart defects: Current knowledge: A scientific statement from the American Heart Association Congenital Cardiac Defects Committee, Council on Cardiovascular Disease in the Young: Endorsed by the American Academy of Pediatrics [ J ]. Circulation, 2007, 115(23) :3015 -3038.
7Oyamada M, Oyarnada Y, Takanatsu T. Regulation of connexin expression[J]. Biochimi BiophYSi Acta, 2005, 1719(1 -2) :6 -23.
9Gong LG, Qiu GR, Xin N, et al. Cloning ofTBXS, a key gene during heart formation and its expression in rat embryonic heart [ J]. Yi Chuan Xue Bao, 2006, 33 (3) : 199 - 205.